Skip to main content

Table 2 Baseline clinical characteristics of the female study population

From: Recovery of serum testosterone levels is an accurate predictor of survival from COVID-19 in male patients

  Mild-moderate
N=145
Severe-recovered
N=76
Severe-deceased
N=27
p-value1–2 p-value1–3 p-value2–3
Age (years) median (IQR) 57 (54–60) 55 (53–62) 74 (68–81) 0.9999 <0.0001 <0.0001
Length of stay (days), median (IQR) 7 (6–7) 25 (20.0–33.0) 15 (8–19) <0.0001 0.0033 0.0003
Comorbidity, n° (%) 89 (61.38) 47 (61.84) 22 (81.48) 0.9999 0.0503 0.0942
Hypertension 43 (29.65) 20 (26.31) 14 (51.85) 0.6408 0.0431 0.0190
Diabetes 20 (13.79) 6 (7.89) 2 (7.41) 0.2719 0.5343 >0.9999
Cancer 9 (6.21) 5 (6.58) 4 (14.81) 0.9999 0.1259 0.2366
Cardiovascular diseases 11 (7.58) 5 (6.58) 3 (11.11) 0.9999 0.4637 0.4290
Chronic Lung diseases 12 (8.27) 8 (10.53) 6 (22.22) 0.6249 0.0413 0.1877
Obesity-Dyslipidaemia 43 (29.65) 28 (36.84) 8 (29.63) 0.2916 0.9999 0.6396
Chronic Kidney disease 5 (3.49) 2 (2.63) 2 (7.41) 0.9999 0.3024 0.2805
Others 20 (13.79) 11 (14.47) 5 (18.52) 0.9999 0.5453 0.5461
Biochemical parameters, median (IQR)
Leucocytes n° 5.95 (5.40–6.81) 6.28 (5.46–7.02) 7.29 (5.74–9.07) 0.9999 0.2849 0.6427
Lymphocytes n° 1.18 (1.04–1.27) 1.00 (0.84–1.12) 0.89 (0.74–1.21) 0.0008 0.0349 0.9999
Lymphocytes % 19.76 (17.96–22.16) 15.65 (16.62–18.58) 13.40 (9.59–19.18) 0.0009 0.0025 0.9999
Neutrophils n° 4.02 (3.6–4.78) 4.88 (4.23–5.43) 5.83 (4.37–7.66) 0.2125 0.0649 0.9426
Interleukine-6 34.21 (26.81–38.60) 75.30 (50.26–86.23) 65.36 (45.03–154.6) <0.0001 <0.0001 0.9999
C-reactive protein 8.38 (4.78–10.44) 12.67 (10.44–14.99) 14.47 (6.43–21.89) 0.0042 0.0846 0.9999
LDH 304 (289.0–345.0) 420.0 (380.0–486.0) 415.0 (283.0–539.0) <0.0001 0.0855 0.9999
D-Dimer 258.0 (228.0–275.0) 334.0 (258.0–422.0) 269.0 (207.0–424.0) 0.0379 0.7287 0.9999
Ferritin 378.0 (284.0–437.0) 528.0 (445.0–729.0) 445.0 (387.0–730.0) 0.0023 0.3007 0.9999
  1. The Fisher’s exact test was used to compare comorbidities. The Kruskal-Wallis test with Dunn’s multiple comparison was used to analyze the length of stay and biochemical parameters
  2. 1Mild-moderate group, 2Severe-recovered group, 3Severe-deceased group